Lv1
60 积分 2023-02-19 加入
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial
17天前
已完结
Drug resistance in breast cancer: Mechanisms and strategies for management
2个月前
已完结
Unveiling the molecular and immunological drivers of antibody-drug conjugates in cancer treatment
2个月前
已完结
Triggering ferroptosis to tackle cancer
2个月前
已关闭
Decoding TNBC architecture
2个月前
已完结
Decoding ferroptosis for cancer therapy
2个月前
已完结
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade
3个月前
已完结
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
4个月前
已完结
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
5个月前
已完结
皖公网安备34019202002308
